To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Welsh Carson doubles money on exit(2)
Welsh, Carson, Anderson & Stowe has sold AmeriPath for $2 billion; it took the cancer and genomics diagnostics company private in 2003 in a transaction valued at $839.4 million.
